在CAR T细胞治疗后,扩散的大B细胞淋巴瘤转化为差异化瘤
Nandan Padmanabha1, Matthew J Weinstock2, Sean Xu1
1Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Journal of hematopathology
|June 15, 2024
概括
化学抗原受体T细胞 (CAR-T) 治疗可以导致罕见的B细胞恶性瘤转化为差异化瘤. 本研究详细介绍了一个案例,展示了CAR-T耐药性和诊断挑战.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 精准医学是一门精准的医学.
背景情况:
- 化学抗原受体T细胞 (CAR-T) 疗法为复发性或耐火性B细胞恶性瘤提供了一个有前途的方法.
- 在形态学,免疫表型和基因组学方面可能发生罕见但显著的治疗后变化.
相关概念视频
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Forced Transdifferentiation
1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
1.9K


